Trial intelligence / Profile preview

Oral azacitidine plus best supportive care versus placebo plus best supportive care in lower-risk myelodysplastic syndrome

2022-500479-29-00Phase 3Authorised

Sponsor

Celgene Corporation

Start

Mar 2023

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules

Countries

20